These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 15579375

  • 1. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
    Jensen J, Krakauer M, Sellebjerg F.
    Cytokine; 2005 Jan 07; 29(1):24-30. PubMed ID: 15579375
    [Abstract] [Full Text] [Related]

  • 2. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul 07; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

  • 3. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 1998 Jul 07; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 4. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 5. The adhesion molecule and cytokine profile of multiple sclerosis lesions.
    Cannella B, Raine CS.
    Ann Neurol; 1995 Apr 15; 37(4):424-35. PubMed ID: 7536402
    [Abstract] [Full Text] [Related]

  • 6. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct 15; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 7. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D, Thomas AV, Petereit HF, Fink GR, Schroeter M.
    Neuroimmunomodulation; 2009 Oct 15; 16(6):385-91. PubMed ID: 19609087
    [Abstract] [Full Text] [Related]

  • 8. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.
    Scand J Immunol; 2006 Aug 15; 64(2):155-63. PubMed ID: 16867161
    [Abstract] [Full Text] [Related]

  • 9. Interferon-beta 1b leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis.
    Kraus J, Bauer R, Chatzimanolis N, Engelhardt B, Tofighi J, Bregenzer T, Kuehne BS, Stolz E, Blaes F, Morgen K, Traupe H, Kaps M, Oschmann P.
    J Neurol; 2004 Apr 15; 251(4):464-72. PubMed ID: 15083294
    [Abstract] [Full Text] [Related]

  • 10. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
    Lou J, Gasche Y, Zheng L, Giroud C, Morel P, Clements J, Ythier A, Grau GE.
    Lab Invest; 1999 Aug 15; 79(8):1015-25. PubMed ID: 10462039
    [Abstract] [Full Text] [Related]

  • 11. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D, Kanno H, Yoshida A, Kurose A, Akasaka T, Sawai T.
    Br J Dermatol; 2007 Aug 15; 157(2):259-65. PubMed ID: 17596165
    [Abstract] [Full Text] [Related]

  • 12. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally.
    Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P.
    Headache; 2006 Feb 15; 46(2):200-7. PubMed ID: 16492228
    [Abstract] [Full Text] [Related]

  • 13. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F, Di Marco R, Patti F, Zaccone P, L'Episcopo MR, Reggio E, Xiang M, Nicoletti A, Reggio A.
    Cytokine; 2000 Jun 15; 12(6):682-7. PubMed ID: 10843745
    [Abstract] [Full Text] [Related]

  • 14. Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.
    Graber J, Zhan M, Ford D, Kursch F, Francis G, Bever C, Panitch H, Calabresi PA, Dhib-Jalbut S.
    J Neuroimmunol; 2005 Apr 15; 161(1-2):169-76. PubMed ID: 15748956
    [Abstract] [Full Text] [Related]

  • 15. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep 15; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 16. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK, Sancricca C, Mirabella M, Tonali PA, Batocchi AP.
    J Neurosci Res; 2006 Oct 15; 84(5):1027-36. PubMed ID: 16865709
    [Abstract] [Full Text] [Related]

  • 17. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 15; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 18. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 15; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 19. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
    Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF.
    Ann Neurol; 1997 May 15; 41(5):669-74. PubMed ID: 9153530
    [Abstract] [Full Text] [Related]

  • 20. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
    Chatzimanolis N, Kraus J, Bauer R, Engelhardt B, Bregenzer T, Kuehne BS, Tofighi J, Laske C, Stolz E, Blaes F, Voigt K, Traupe H, Kaps M, Oschmann P.
    Acta Neurol Scand; 2004 Dec 15; 110(6):377-85. PubMed ID: 15527450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.